Just to recap some of the positive things about ACT.....
Gary R. mentioned that ACT is very excited about the trial results and information will be released w/highest scientific standard and a General Media Plan. We have the opportunity to make medical history and will not take shortcuts. Will announce as soon as possible.
Gary R. responded that The outside date of Clinical Results Announcement: Highly coordinated strategy that involves both scientific and general media dissemination of this information about the patients that is very personal & detailed and hands on and we feel that this is the best way from both a scientific and shareholder perspective to disseminate and legitimze this information. We have been working through this process for 6-8 weeks (that was mentioned beginning Nove) and we are getting down the the home stretch. (which means we should be hearing news very soon).
It was mentioned that ACT will be adding some new board members and said the shareholders would be very pleased with their choices.
I would like to say that there are so many positive things going on....the potential China JV, the fact that the patients want their other eye injected; the blood and heart projects, the many many patents; ACT has the only FDA approved clinical trial...They are working on having trials in Europe and Asia and don't damage the embryo!!!
Part of an article from Retina Today, March 2011: animals, injection of hESC-derived RPE cells resulted in 100% improvement in visual performance over control animals and extensive rescue of photoreceptors. In untreated control animals, the outer nuclear layer of photoreceptors was approximately one cell deep at 100 days after injection. In the treated animals, that layer was five to seven cells deep at that time point. In a mouse model of Stargardt disease, the RPE cell treatment resulted in near-normal visual function for the 2 to 3 months that the animals were observed.
Keep your eye on the ball. It's just a matter of time.....
Investing in "pennies" can be frustrating. With any speculative stock and new technologies, instant gratification, which many investors seek is not an option. In this case, the reward will come with patience and belief in the science. SS
Ohara, if there has to be balance, then we definitely don't need you here - we already have more than our fair share of bashers.
Your voice is just excess noise in the bloated cacaphony of basher nonsense.
I would like to openly thank you for your resolve. I say this because only in an open discussion, fair and balanced can investors make informed decisions. You do add value with your perspective so stick around!
Check this link out, not ever a year ago, from Ohara...LOL.
Yep, that's his poker tell, no doubt about it. Ohara desperately wants to buy in, but his greed won't let him because he's convinced himself that the pps will drop, and he's so short-sighted he can't see that any pps under a buck is a steal.
Ohara, here's a suggestion:
Forget about ACTC - it is obviously not for you. You do not understand that some stocks should be held long-term. As you so profoundly pointed out, there are other stocks out there, so why not take your own advice? Seriously, TAKE YOUR OWN ADVICE! Go invest somewhere else, and take your vitriolic posts with you.
or, one could frequent a message board with a better shareholder value and performance, say, any one of a few thousand publicly trades stocks...yet you are still here. LOL LOL LOL, I wonder why????
I have never sold any of my ACTC holdings, so please explain how I am losing money. I'm listening...
But it sounds like you answered your own question. Unless you're talking about your failure to comprehend the correct placement of decimals, in which case the answer is "Yes", your screwing up the decimals is truly pathetic.